GENE ONLINE|News &
Akebia Therapeutics to Participate in Raymond James 2026 Biotech Innovation Symposium on April 7
Akebia Therapeutics announced plans to participate in investor meetings during the Raymond James 2026 Biotech Innovation Symposium. The company confirmed its attendance at the event, which is scheduled to take place on April 7, 2026. Akebia intends to engage with investors and stakeholders as part of its ongoing efforts to provide updates on its business operations and strategic initiatives.
The symposium, hosted by Raymond James, serves as a platform for biotech companies to connect with investors and discuss advancements within the industry. Akebia Therapeutics has not disclosed specific details regarding its presentations or topics of discussion but emphasized its commitment to fostering transparency and communication with shareholders.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 7, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Researchers Develop Method to Convert Ketones into Saturated Heterocycles for Pharmaceutical Applications
2026-04-15
Naturally Occurring Compounds Luteolin, Naringenin, and Scutellarin Identified as Potential Inhibitors of Breast Cancer-Linked Enzymes HDAC4 and HDAC8
2026-04-15
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
